Figure 2

Overall, event-free survival and relapse-free survival analyses of OS patients correlated with gene expression profiling of either biopsy or primary tumor resection onset groups. A- Overall, event-free survival and relapse-free survival of biopsy onset group with over-expression of THBS3, and relapse-free survival of primary tumor resection onset group with over-expression of THBS3. B- Overall, event-free survival and relapse-free survival of biopsy onset group with over-expression of SPARC.C- Overall, event-free survival and relapse-free survival of biopsy onset group with over-expression of the SPP1 gene.